Start-Up Previews, December 2015
In this month's issue of Start-Up, we profile Flow Forward, Intensity Therapeutics, Perimeter Medical Imaging, PhageTech and Pulmotect.
You may also be interested in...
The most desirable form of vascular access for most hemodialysis patients is an arteriovenous fistula (AVF). Flow Forward believes it can expand the AVF prevalence rate to 90% with its Arteriovenous Fistula Eligibility (AFE) System, a temporary external blood pump that rapidly dilates peripheral veins prior to AVF surgery.
A handheld biosensor in development by PhageTech Inc. is designed to detect the presence of several biomarkers associated with the recurrence of bladder cancer from a small urine sample, without the need for expensive and time-consuming lab-based tests. The device could also monitor treatment.
The Optical Tissue Imaging System (OTIS) from Toronto-based Perimeter Medical Imaging Inc. uses laser light to penetrate tissue and measure the density of different tissue types at a resolution roughly eight times that of ultrasound or X-ray. “